Source:http://linkedlifedata.com/resource/pubmed/id/11254523
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
2001-3-20
|
pubmed:abstractText |
Lower baseline antipneumolysin antibody (alpha-PLY) levels have been found in populations with a higher incidence of pneumococcal infections. To determine whether predisease alpha-PLY titer is associated with invasive pneumococcal disease in HIV-seropositive injection drug users (IDU), we utilized a prospective cohort of IDU in Baltimore to compare alpha-PLY titers before bacteremia in 28 HIV- seropositive IDU cases with alpha-PLY titers in 56 matched (CD4 and seroconversion date) HIV-seropositive IDU control subjects and 28 matched (calendar time) HIV-seronegative IDU control subjects remaining free of pneumococcal disease. We also compared the postinfection fold-rise of alpha-PLY titers in cases relative to the change in alpha-PLY titers in control subjects during the same interval; alpha-PLY titers were measured using quantitative ELISA, and functional activity was assessed using antihemolysin assays. Predisease alpha-PLY titer did not differ between cases (66 units) and HIV-seropositive control subjects (70 units, p = 0.56) or HIV-seronegative control subjects (80 units, p = 0.10). There was a significant difference in fold-rise of alpha-PLY titers postdisease between cases (1.18) and HIV-seronegative control subjects (0.76), p = 0.03. Baseline alpha-PLY titers do not differ significantly between HIV-seropositive IDU who develop pneumococcal bacteremia from HIV-seropositive and HIV-seronegative IDU control subjects remaining free of severe pneumococcal disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cytotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Streptolysins,
http://linkedlifedata.com/resource/pubmed/chemical/plY protein, Streptococcus...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1073-449X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
680-4
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11254523-Adolescent,
pubmed-meshheading:11254523-Adult,
pubmed-meshheading:11254523-Antibodies,
pubmed-meshheading:11254523-Bacteremia,
pubmed-meshheading:11254523-Bacterial Proteins,
pubmed-meshheading:11254523-CD4 Lymphocyte Count,
pubmed-meshheading:11254523-Case-Control Studies,
pubmed-meshheading:11254523-Cytotoxins,
pubmed-meshheading:11254523-Female,
pubmed-meshheading:11254523-HIV Seropositivity,
pubmed-meshheading:11254523-Humans,
pubmed-meshheading:11254523-Male,
pubmed-meshheading:11254523-Pneumococcal Infections,
pubmed-meshheading:11254523-Prospective Studies,
pubmed-meshheading:11254523-Streptolysins,
pubmed-meshheading:11254523-Substance-Related Disorders
|
pubmed:year |
2001
|
pubmed:articleTitle |
Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia.
|
pubmed:affiliation |
Johns Hopkins School of Medicine and Johns Hopkins School of Public Health, Department of International Health, Baltimore, Maryland; , USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|